| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |